Coagentus Pharma, LLC

Our Focus in 4 Key Areas 

Pharmaceutical

Having worked with many CRO partnerships throughout the world with experience serving the top 50 pharmaceutical companies, we have the resources to conduct global clinical trials across six continents.

Biotechnology

Our Team appreciates the vital role of biotechnology companies in meeting market demands for innovative therapeutic and diagnostic products.

Government and Public Health

COAGENTUS collaborates with government and nonprofit organizations to deliver global support of therapeutic, vaccine, epidemiological and prevention studies.

Medical Device

Clients can accelerate the process of bringing their new products to market with the experience, resources and global reach of the COAGENTUS medical device development team.

COAGENTUS Group

COAGENTUS holds 100% equity ownership in the following companies:

• G Biotics, LLC. : Targeting Guanylate Cyclase C (GCC) in Probiotics and Dietary Supplements for Intestinal Health to improve appetite control to prevent obesity and metabolic diseases (diabetes, metabolic syndrome, heart disease) and to prevent colorectal cancer

• Adoptive Immunotherapies, LLC.: GUCY2C-directed CAR-T cells Therapy: Adoptive T-cell therapy (ACT) is an emerging paradigm in which T cells are genetically modified to targetcancer-associated antigens and eradicate tumors. Our goal is to treat patients with metastaticcolorectal cancer without collateral autoimmunity.

• TJU Asset Mangement, LLC.

• Penn LifeScience, LLC.

Our Board Members

Scott A. Waldman, MD, PhD, FCP, FAHA

• Dr. Waldman’s career has focused on integrating basic, translational and clinical research in transmembrane signaling to advance laboratory discovery into patients.  His work has produced >300 publications (h index=59, >14,000 citations) and >60 patents and patent applications.  
• His discoveries have been licensed by 7 companies and have been the focus of >15 clinical trials.  Beyond research, he is an internationally-recognized leader in the field of clinical pharmacology.  
• He is the Editor-In-Chief of Clinical Pharmacology & Therapeutics, Founder and Editor-In-Chief of Biomarkers In Medicine, and Founder and former Deputy Editor-In-Chief of Clinical and Translational Science.  
• He is a retired Chair of NCI Subcommittee J
• He is the Chair of the FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee.
• He is a recurring member of the FDA Oncology Drugs and the Arthritis Drugs Advisory Committee. 
• He is a Past President of the American Society for Clinical Pharmacology and Therapeutics, a former Regent of the American College of Clinical Pharmacology, and the former Secretary/Treasurer of the American Board of Clinical Pharmacology.  Institutionally, he directs the KCC Gastrointestinal (GI) Malignancies Program; the M.D.-Ph.D. Program; and the Postdoctoral Training Program in Clinical Pharmacology (5T32 GM08562).
• He is Chairman (tenured), Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA.
• MD, Stanford University
• PH.D., Thomas Jefferson University

Harry A. Arena, MBA

• Founder and managing partner of a large suburban public accounting firm.  Financial advisor to numerous executives and companies, in various industries such as construction, real estate, law, biotechnology, and many others.
• Financial executive. CFO, CEO, and founder of several companies, including biotechnology companies. 
• Formed the corporation, raised initial equity, and follow up rounds, negotiated large licensing deals with U.S. and foreign pharmaceutical companies.  Directed all financial and legal activities
• President & CEO, Chairman of the Board of Directors, and co-founder - Targeted Diagnostics & Therapeutics, Inc., Exton, PA
• Founded and managed large suburban public accounting firm, with clients of various size, up to app $200 million in revenues, from numerous industries.
• Founder and Managing Partner, Arena, Snyder & Dunlap LLP – CPA Exton, PA
• Corporate Treasurer and Director, Gen Trak, Inc. – Biotechnology Company, Plymouth Meeting, PA 
• Audit Manager, Price Waterhouse & CO – CPA San Jose, CA and Philadelphia, PA 
• MBA Finance, Stanford Graduate School of Business, Palo Alto, CA
• A.B. Economics/Accounting, Holy Cross College, Worcester, MA, National Merit Scholar

Chris Kim, JD, LLM

• He is of counsel for DeHeng Law Office NY, the largest law firm in China. 
• After graduating from Yonsei University, Seoul, Korea and University of Pennsylvania Law School in Philadelphia, he has extensive international experience that has involved transactions on behalf of companies in Asia, Europe as well as North America including, but not limited to, Wal-Mart, IBM, Sony, GE, Toyota, Deutsche Bank, UBS, Samsung, Korea Telecom (with British Telecom, AT&T, and Sprint on telecommunication projects in Taiwan, South America and East Asia), Dong A Group (Power plant projects - corporate financing), and Lotte.
• In addition, Mr. Kim has been instrumental in introducing Walmart, Hugo Boss, Jaeger, Sizzler, DKNY, Outback Restaurant, Epson, Gymboree, Sanrio Japan, and other international corporations into the Korea markets.
• Mr. Kim has overseen the international finance and M&A section at law firms where he has advised on the most appropriate acquisition structure among statutory mergers, forward mergers, reverse mergers, triangular mergers, reverse triangular mergers, stock acquisitions, asset purchases, tender offers and management takeovers.
• Mr. Kim also has over 10 years of experience in intellectual property law, including patent, trademark, copyright, trade secret, unfair competition and other related areas. He has been an IP counsel to Merck and Co., Johnson & Johnson, Pfizer, GlaxoSmithKline, Novartis, Abbott Laboratories, Bayer Healthcare, and top 50 pharmas in the world.

Potential Academic Clinical Sites

• Thomas Jefferson University
• MD Anderson
• Duke University DCRI
• Cleveland Clinic
• Harvard University Joslin Center
• Standford University
• Mayo Clinic
• Thomas Jefferson University
• Yale University Med School 
• U Penn Medical School
• And other Major University Med Schools and Hospitals and Clinical Research Centers